Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > $1.9M sales contract

<< Previous

Bullboard Posts

Next >>

Comment by postie1on May 28, 2024 3:24pm

105 Views

Post# 36060930

RE:RE:$1.9M sales contract

One would think this should be the start of attaining credibility for getting financing . That is just 1 product in 2 latin american countries and 4 more products to go,. Big plus that the distributer is going to pay for approval as that saves VM money that is scarce right now. Just cannot fathom anybody willing to sell at this price with the sales in the big markets that should come over the next year or so. Do not be surprised if someone uses a short strategy in order to buy some cheap shares by shaking the weak kneed. DYDD

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch